A study to Assess the Pharmacokinetics of AZD4831 when Administered Alone and in Combination with Itraconazole

Trial Identifier: D6580C00013
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05236543
Start Date: February 2022
Primary Completion Date: August 2022
Study Completion Date: August 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ